Insights

Foley & Lardner is hosting the International Trademark Association’s (INTA) Annual Case Law Review in our Milwaukee office on Friday, January 30, 2026.

Key Takeaways U.S. privacy compliance has become significantly more complex due to the rapid growth of state consumer privacy laws, each…

The health care and life sciences sector is entering a period of accelerated transformation shaped by new technologies, shifting…

In In Re Gesture Technology Partners, LLC, Case No. 2025-1075 (Fed. Cir. December 1, 2025) (“Gesture”), the Federal Circuit reinforced…

In this special edition of The Path & The Practice, Alexis is joined by Dan Sharpe, DEI Manager at Foley & Lardner, for a conversation focused on advice to new associates. Based on their years of legal practice and their experience working in law firm talent development and DEI, they cover a variety of topics including time entry, meeting deadlines, responsiveness, and office presence.

In this episode, Lauren Carboni, co-chair of Foley’s Health Care Litigation Area of Focus, is joined by Chanda Hinton, Founder and Executive Director of The Chanda Center for Health, a pioneering nonprofit dedicated to empowering individuals with long-term physical disabilities.

This special edition of The Path & The Practice welcomes members of Foley’s Veterans & Allies Affinity Group, Patrick McMahon (Senior Counsel, Labor & Employment, Chicago), Alexa Goldstein (Associate, Litigation, Tampa), and Rashad Abdallah (Associate, Labor & Employment, San Diego).

On January 20, 2026, President Trump signed an Executive Order (EO) titled Stopping Wall Street from Competing with Main Street Homebuyers. It seeks to curb the role of large institutional investors, such as private equity (PE) firms, in the single-family housing market. Key provisions direct federal agencies to take steps to prevent financial firms from acquiring homes, to “preserve the supply of single-family homes for American families and increase the paths to homeownership.”

On January 14, 2026, President Trump issued a proclamation following an investigation by the U.S. Secretary of Commerce (Secretary), under Section 232 of the Trade Expansion Act of 1962 (19 U.S.C. 1862) (Section 232), into the effects of imports of processed critical minerals and their derivative products (Critical Minerals) on the national security of the United States.

Any company that has imported goods subject to the Trump administration’s fentanyl-based tariffs or reciprocal tariffs — i.e., the tariffs levied pursuant to the International Emergency Economic Powers Act (the IEEPA tariffs) — needs to consider filing an action in the U.S. Court of International Trade (CIT) to preserve the possibility of recovering refunds of these tariffs.